Drug Interactions with Antacids. Mechanisms and Clinical Significance
Overview
Authors
Affiliations
Concomitant use of antacid preparations with other medications is common. The potential for antacid-drug interactions is dependent upon the chemistry and physical properties of the antacid preparation. The intragastric release of free aluminum and magnesium ions has potent effects on gastrointestinal function and on drug pharmacokinetics. Antacid-drug interactions may occur secondary to changes in gastrointestinal motility or alterations in gastric and urinary pH. Direct adsorption also results in decreased drug bioavailability. Human drug interaction studies are usually performed with healthy volunteers; extrapolation of these results to clinical situations may not always be valid. However, the current literature would suggest that significant interactions with antacids do occur with certain members of the quinolone, nonsteroidal anti-inflammatory drug (NSAID) and cephalosporin classes of drugs. Notable interactions also occur with tetracycline, quinidine, ketoconazole and oral glucocorticoids. These interactions are particularly relevant in the patient with sepsis, cardiac disease or inflammatory syndromes.
Concomitant prescription of oral fluoroquinolones with an antacid preparation.
Jhaj R, Sivagnanam G J Pharmacol Pharmacother. 2013; 4(2):140-2.
PMID: 23761711 PMC: 3669574. DOI: 10.4103/0976-500X.110898.
Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers.
Cuzzolin L, Benoni G Pharm World Sci. 2009; 32(1):97-102.
PMID: 19921545 DOI: 10.1007/s11096-009-9348-2.
Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria T Pharm Res. 2005; 22(2):188-92.
PMID: 15783065 DOI: 10.1007/s11095-004-1185-3.
Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
Bentue-Ferrer D, Tribut O, Polard E, Allain H CNS Drugs. 2003; 17(13):947-63.
PMID: 14533945 DOI: 10.2165/00023210-200317130-00002.
Lefevre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D Br J Clin Pharmacol. 2002; 54(5):485-92.
PMID: 12445027 PMC: 1874456. DOI: 10.1046/j.1365-2125.2002.01696.x.